Co-Immunity, founded by Madeline Shonka and Kyle Manera, addresses the communication gap in chronic illness management between patients and providers. Utilizing an AI-driven algorithm, the platform tracks symptoms and facilitates patient engagement, aiming to improve health outcomes and reduce costs associated with miscommunication. With a market potential of $1.4 billion among individuals with autoimmune diseases in the U.S., Co-Immunity has already engaged over 40 patients and initiated pilot programs with healthcare providers.

1. Presented by Madeline Shonka

2. OUR STORY
|
2

3. OUR TEAM
Kyle Manera
Founder and COO
Engineering Background
Madeline Shonka
Fo u n d er an d CEO
Health Care Background
Co-Immunity intimately understands the problem from both the
patient and provider perspective.
|
3

4. JUGGLING THE PROBLEM
|
4
Patients must recall large
amounts of information.
The average time with a
doctor is 15 minutes.
Emotions make effective
communication difficult.

5. PATIENT IMPACT
$3.7
TRILLION
dollars a year spent
o n c h ro n ic illn ess
5
YEARS
on average to diagnose
a c h ro n ic illn ess
6
SPECIALISTS
on average to diagnose
a c h ro n ic illn ess
|
5

6. PROVIDER IMPACT
$425 MILLION DOLLARS A YEAR
30%of malpractice claims are
due to miscommunication.
|
6

7. SYMPTOMS MADE SIMPLE
Tracks and reports over time
Chronic illness flare prediction
Social network for patients
Reminders and notes
|
7

8. MARKET USE
Active Participation in Care
Reflect and Prioritization
Better reporting =Better Treatment
Less Stress, Anxiety, Frustration
Understand Prior to Appointment
Snapshot of Biggest Problems
Data-Driven Diagnosis/Treatment
More Time for Patient Education
Patient
|
8
Provider

9. VALUE PROPOSITION
Full Health Histroy
Proactive Algorithm
Tracks Symptoms
Multiple Diseases
Track <60 seconds
Social Network
Paper/
Memory
Folia
Health
Aila
Health
Co-Immunity
|
9

10. CUSTOMER DISCOVERY TRACTION
30 years as patients
10 years in healthcare
250 patients surveyed
40 provider interviews
Over 3,000 followers
on social media
5,000 conversations
with patients/caregivers.
40 patient users since
September 2021.
One pilot program
with a physician.
|
10

11. MARKET SIZE
Co-Immunity's
MarketShare
All people with Autoimmune
diseases in the USA
Autoimmune diseases (US)
15-49 Years old
11
$1.4B
23 .5 Million
people
$636M
10 .6 Million
people
$23M
450 Thousand
people

12. IP STRATEGY
|
12
Software
Trade Secrets
AI Flare
Algorithm
Provider
Relationships

13. TO BRIDGE THE
COMMUNICATION CHASM
ContactInformation:madeline@coimmunity.co
|
13
WE NEED YOUR HELP
Pilot
Programs
Quality
Improvement

14. Questions?